Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,046 | 65,634 | 95,401 | 35,829 | 39,424 |
| Marketable Securities | 44,815 | 9,499 | N/A | N/A | 996 |
| Receivables | 19,262 | 19,309 | 16,651 | 18,379 | 16,874 |
| Inventories | 14,269 | 13,754 | 13,003 | 15,424 | 15,251 |
| TOTAL | $106,779 | $111,478 | $127,106 | $71,860 | $75,247 |
| Non-Current Assets | |||||
| PPE Net | 8,298 | 8,234 | 8,825 | 9,760 | 10,424 |
| Intangibles | 155,908 | 158,708 | 161,508 | 164,308 | 167,108 |
| Other Non-Current Assets | 12,808 | 13,027 | 6,208 | 6,362 | 6,324 |
| TOTAL | $177,014 | $179,969 | $176,541 | $180,430 | $183,856 |
| Total Assets | $283,793 | $291,447 | $303,647 | $252,290 | $259,103 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,075 | 6,936 | 4,027 | 6,246 | 6,642 |
| Accrued Expenses | 8,281 | 6,222 | 14,470 | 14,526 | 11,880 |
| TOTAL | $37,320 | $34,182 | $37,582 | $38,865 | $36,650 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,972 | 12,325 | 11,464 | 11,511 | 10,756 |
| Other Non-Current Liabilities | 55,220 | 55,549 | 173,908 | 171,518 | 168,762 |
| TOTAL | $73,833 | $75,020 | $193,949 | $191,013 | $187,620 |
| Total Liabilities | $111,153 | $109,202 | $231,531 | $229,878 | $224,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,404 | 69,020 | 68,989 | 39,323 | 39,164 |
| Common Shares | 69 | 69 | 49 | 39 | 39 |
| Retained earnings | -598,069 | -584,316 | -558,851 | -544,075 | -529,325 |
| Other shareholders' equity | -623 | -677 | -687 | -516 | -504 |
| TOTAL | $172,640 | $182,245 | $72,116 | $22,412 | $34,833 |
| Total Liabilities And Equity | $283,793 | $291,447 | $303,647 | $252,290 | $259,103 |